Compare RYTM & LFUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RYTM | LFUS |
|---|---|---|
| Founded | 2008 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.0B |
| IPO Year | 2017 | N/A |
| Metric | RYTM | LFUS |
|---|---|---|
| Price | $112.03 | $259.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | $125.77 | ★ $292.50 |
| AVG Volume (30 Days) | ★ 887.7K | 214.2K |
| Earning Date | 11-04-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.74 |
| Revenue | $174,334,000.00 | ★ $2,321,865,000.00 |
| Revenue This Year | $47.34 | $10.60 |
| Revenue Next Year | $57.18 | $8.42 |
| P/E Ratio | ★ N/A | $55.29 |
| Revenue Growth | ★ 54.92 | 5.78 |
| 52 Week Low | $45.91 | $142.10 |
| 52 Week High | $122.20 | $275.00 |
| Indicator | RYTM | LFUS |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 53.99 |
| Support Level | $109.59 | $252.20 |
| Resistance Level | $122.20 | $274.25 |
| Average True Range (ATR) | 5.23 | 7.44 |
| MACD | 1.04 | 1.37 |
| Stochastic Oscillator | 54.25 | 47.59 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
Littelfuse is a primary provider of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. The company is also increasing its power semiconductor business, where it predominantly serves industrial end markets, and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.